Related Experiment Videos
Multicentre study of propofol in day case surgery.
1ICI Pharmaceuticals, UK, Macclesfield, Cheshire.
Anaesthesia
|March 1, 1988
Summary
Propofol, a key anesthetic, demonstrated safe and effective use in routine day case surgeries. This study confirms its efficacy and rapid recovery profile in a broad patient population outside clinical trials.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Propofol is a widely used intravenous anesthetic agent.
- Evaluating propofol's efficacy and safety in routine clinical practice is essential post-launch.
Purpose of the Study:
- To assess propofol's utility as a primary anesthetic in diverse day case surgical procedures.
- To document adverse events and recovery characteristics in a real-world clinical setting.
Main Methods:
- An open, multicenter study involving 879 patients undergoing various day case surgeries.
- Propofol was the main anesthetic, with limited use of supplementary agents like fentanyl, alfentanil, or nitrous oxide.
- Exclusion of volatile anesthetics to isolate propofol's effects.
Main Results:
- Smooth induction observed in 91.6% of patients, with minimal adverse effects.
- Mean anesthesia duration was 12 minutes 12 seconds, with a mean propofol dosage of 10.6 mg/kg/hour.
- Rapid recovery noted, with patients oriented within approximately 1 minute; low incidence of postoperative nausea and vomiting.
Conclusions:
- Propofol is a safe and effective anesthetic for a wide range of day case surgeries in routine clinical settings.
- The study highlights propofol's favorable safety profile, rapid recovery, and low incidence of side effects.
- Pain on injection, occurring in 25% of patients, was mitigated by using larger veins.